Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance

Meridian Bioscience (VIVO) Declares $0.20 Quarterly Dividend; 4.1% Yield

November 5, 2015 9:31 AM EST

Meridian Bioscience (NASDAQ: VIVO) declared a quarterly dividend of $0.20 per share, or $0.8 annualized.

The dividend will be payable on November 27, 2015, to stockholders of record on November 16, 2015, with an ex-dividend date of November 12, 2015.

The annual yield on the dividend is 4.1 percent.

For... More

Meridian Bioscience (VIVO) Misses Q4 EPS by 1c

November 5, 2015 9:31 AM EST

Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $47.1 million versus the consensus estimate of $46.6 million.

For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.

... More